Improving Cervical Cancer Prevention Among Women Living With Chronic Conditions.
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age25+
SponsorUniversity of Florida
About this trial
Our overarching goal is to adapt and test the PINPOINT intervention -PatIent Navigation for the Prevention of CervIcal CaNcer inTervention. We will test the PINPOINT intervention among patients with high-risk profiles for cervical cancer who do not meet the recommended screening for cervical cancer.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Using the American Cancer Society (ACS) screening recommendations, adults aged over the age of 25 will be eligible
Active UF Internal Medicine patient and has had an appointment in the last 2 months.
Assigned sex at birth is female
Have Obesity or Type 2 Diabetes
Disqualifiers
Previous history of cervical cancer
Total hysterectomy
Pregnant
Trial design
Design model
Parallel
Treatments tested in this trial
patient navigation and self-collection
BehavioralPatients will receive a combination of patient navigation, education, and cervical cancer self-collection sampling as part of the intervention to support cervical cancer screening.
Treatment groups
20 Participants
are divided into 2 treatment groupsGroup A: InterventionExperimental treatment 1 intervention
Group B: Control ArmNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Cervical cancer screening
receiving cervical cancer screening either via self-collection, pap smear, or hpv testing
Time frame
within 6 monthsSecondary outcomes
1
Acceptability
How agreeable or satisfactory participants find the intervention or implementation strategy. Questions include, HPV Self-Collection meets my approval, HPV Self-Collection is appealing to me, I like HPV Self-Collection, and I welcome HPV Self-Collection. Participants will fill a 4 point likert scale for each, (completely disagree, disagree, neither agree not disagree, agree, completely agree).
Time frame
from enrollment until they complete screening or at the end of the trial at 6 months2
Appropriateness
The perceived fit or compatibility of the intervention for a specific setting, provider, or consumer, or to address a problem. Questions include, HPV Self-Collection seems fitting, HPV Self-Collection seems suitable, HPV Self-Collection seems applicable., and HPV Self-Collection seems like a good match. Participants will fill a 4 point likert scale for each, (completely disagree, disagree, neither agree not disagree, agree, completely agree).
Time frame
from enrollment until they complete screening or at the end of the trial at 6 months3
Feasibility measure
\- The extent to which an intervention can be successfully used in a given setting. Questions include, HPV Self-Collection seems implementable, HPV Self-Collection seems possible, HPV Self-Collection seems doable, and HPV Self-Collection seems easy to use. Participants will fill a 4 point likert scale for each, (completely disagree, disagree, neither agree not disagree, agree, completely agree).
Time frame
from enrollment until they complete screening or at the end of the trial at 6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Florida
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov